ResMed (RMD) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | 0.45 | 0.55 | 1.00 | 0.41 | -0.19 | -0.39 | ||
| Changes by years, y/y, % | -47% | +21% | +82% | -58% | -145% | |||
ResMed. Debt/EBITDA
ResMed. Debt/EBITDA, changes, %
ResMed (RMD) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | LTM ? | |||
| Debt/EBITDA | -0.06 | -0.19 | -0.27 | -0.20 | -0.39 | -0.39 | ||
| Changes by years, y/y, % | -110% | -144% | -203% | -210% | +549% | |||
| Changes by quarters, q/q, % | -132% | +210% | +46% | -24% | +90% | |||